| mRNA |
GDC-0449 |
GDSC1000 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0048 |
0.9 |
| mRNA |
PD-0332991 |
CCLE |
pan-cancer |
AAC |
-0.0068 |
0.9 |
| mRNA |
A-443654 |
GDSC1000 |
pan-cancer |
AAC |
0.0068 |
0.9 |
| mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
| mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |
| mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
| mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
0.0077 |
0.9 |